Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial

被引：0
|
作者：
Heinz, J. [1 ]
Domroese, U. [2 ]
Luley, C. [2 ]
Westphal, S. [3 ]
Kropf, S. [3 ]
Neumann, K. H. [2 ]
Dierkes, J. [3 ]
机构：
[1] Univ Hosp Magdeburg, Inst Clin Chem, D-39120 Magdeburg, Germany
[2] Univ Hosp Magdeburg, Div Nephrol, D-39120 Magdeburg, Germany
[3] Univ Hosp Magdeburg, Inst Biometry & Med Informat, D-39120 Magdeburg, Germany
来源：
CLINICAL NEPHROLOGY | 2009年 / 71卷 / 03期
关键词：
VASCULAR-DISEASE; FOLIC-ACID; HYPERHOMOCYSTEINEMIA; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 50 条
  • [1] B-VITAMINS AND TOTAL MORTALITY AND CARDIOVASCULAR DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASE. A RANDOMIZED CLINICAL TRIAL
    Dierkes, Jutta
    Heinz, Judith
    Domroese, Ute
    Westphal, Sabine
    Kropf, Siegfried
    Neumann, Klaus Hinrich
    Luley, Claus
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 83 - 83
  • [2] B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease Results of a Randomized Controlled Trial
    Heinz, Judith
    Kropf, Siegfried
    Domroese, Ute
    Westphal, Sabine
    Borucki, Katrin
    Luley, Claus
    Neumann, Klaus H.
    Dierkes, Jutta
    CIRCULATION, 2010, 121 (12) : 1432 - 1438
  • [3] Reducing cardiovascular morbidity and mortality from hypertension in end-stage renal disease
    Picton, ML
    Foley, RN
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (05): : 497 - 500
  • [4] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [5] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [6] Surgical mortality and morbidity in patients with end-stage renal disease (ESRD).
    Chertow, GM
    Henderson, W
    Khuri, S
    Hur, K
    Daley, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0639 - A0639
  • [7] Hypocalcemia, morbidity, and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    Hu, LQ
    ODea, R
    Murray, DC
    Barre, PE
    AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (05) : 386 - 393
  • [8] Vitamin D supplementation and mortality in patients with end-stage renal disease
    Dierkes, J.
    Kropf, S.
    Machlitt, P.
    Domroese, U.
    Neumann, K.
    Westphal, S.
    Luley, C.
    Heinz, J.
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 : 326 - 326
  • [9] Strategies to decrease cardiovascular mortality in patients with end-stage renal disease
    Dikow, R
    Adamczak, M
    Henriquez, DE
    Ritz, E
    KIDNEY INTERNATIONAL, 2002, 61 : S5 - S10
  • [10] Trends in end-stage renal disease - Epidemiology, morbidity, and mortality
    Reikes, ST
    POSTGRADUATE MEDICINE, 2000, 108 (01) : 124 - +
12345